Literature DB >> 17301119

Expression of ephrinB1 and its receptor in glaucomatous optic neuropathy.

Jimena F Schmidt1, Olga A Agapova, Ping Yang, Paul L Kaufman, M Rosario Hernandez.   

Abstract

OBJECTIVE: To determine ephrinB1, ephrinB2 and EphB1 expression in the optic nerve head (ONH) and retina of monkeys with glaucoma and in human ONH astrocytes.
METHODS: Using immunohistochemistry, the localisation of ephrinB1, ephrinB2 and EphB1 was determined in the ONH and retina bilaterally in monkeys with monocular laser-induced glaucoma. RT-PCR, western blot and immunocytochemistry were used to study ephrinB1, ephrinB2 and EphB1 expression in cultured human ONH astrocytes from donors with and without glaucoma.
RESULTS: There was an increase in ephrinB1 and EphB1 expression in mild to moderate glaucoma. In the ONH, both ephrinB1 and EphB1 were localised to astrocytes and EphB1 was also localised to lamina cribrosa cells and perivascular cells. In the retina, ephrinB1 localised to Muller cells and astrocytes, and EphB1 was found in retinal ganglion cells. In ONH astrocytes in humans with glaucoma, ephrinB1 and EphB1 were up-regulated but barely present in donors without glaucoma.
CONCLUSIONS: Ephrins are activated in early and moderate glaucoma in the ONH and retina. We postulate that the up-regulation of Eph/ephrin pathway may play a protective role by limiting axonal damage and inflammatory cell invasion. Loss of ephrin signalling in advanced glaucoma may explain macrophage activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17301119      PMCID: PMC1954885          DOI: 10.1136/bjo.2006.112185

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  44 in total

1.  In vitro evaluation of reactive astrocyte migration, a component of tissue remodeling in glaucomatous optic nerve head.

Authors:  G Tezel; M R Hernandez; M B Wax
Journal:  Glia       Date:  2001-05       Impact factor: 7.452

Review 2.  Control of cell behaviour by signalling through Eph receptors and ephrins.

Authors:  G Mellitzer; Q Xu; D G Wilkinson
Journal:  Curr Opin Neurobiol       Date:  2000-06       Impact factor: 6.627

3.  Expression of small heat shock proteins and intermediate filaments in the human optic nerve head astrocytes exposed to elevated hydrostatic pressure in vitro.

Authors:  M Salvador-Silva; C S Ricard; O A Agapova; P Yang; M R Hernandez
Journal:  J Neurosci Res       Date:  2001-10-01       Impact factor: 4.164

4.  The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators.

Authors: 
Journal:  Am J Ophthalmol       Date:  2000-10       Impact factor: 5.258

Review 5.  Optic nerve head structure in glaucoma: astrocytes as mediators of axonal damage.

Authors:  J E Morgan
Journal:  Eye (Lond)       Date:  2000-06       Impact factor: 3.775

6.  Glaucoma is second leading cause of blindness globally.

Authors:  Sharon Kingman
Journal:  Bull World Health Organ       Date:  2004-12-14       Impact factor: 9.408

7.  Selective inhibition of spinal cord neurite outgrowth and cell survival by the Eph family ligand ephrin-A5.

Authors:  Y Yue; J Su; D P Cerretti; G M Fox; S Jing; R Zhou
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

8.  Increased elastin expression in astrocytes of the lamina cribrosa in response to elevated intraocular pressure.

Authors:  J D Pena; O Agapova; B T Gabelt; L A Levin; M J Lucarelli; P L Kaufman; M R Hernandez
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-09       Impact factor: 4.799

9.  The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

Authors:  Michael A Kass; Dale K Heuer; Eve J Higginbotham; Chris A Johnson; John L Keltner; J Philip Miller; Richard K Parrish; M Roy Wilson; Mae O Gordon
Journal:  Arch Ophthalmol       Date:  2002-06

Review 10.  The glaucomas.

Authors:  A L Coleman; L Brigatti
Journal:  Minerva Med       Date:  2001-10       Impact factor: 4.806

View more
  15 in total

1.  Altered vascular expression of EphrinB2 and EphB4 in a model of oxygen-induced retinopathy.

Authors:  Michael H Davies; Andrew J Stempel; Kristin E Hubert; Michael R Powers
Journal:  Dev Dyn       Date:  2010-06       Impact factor: 3.780

2.  Involvement of EphB/Ephrin-B signaling in axonal survival in mouse experimental glaucoma.

Authors:  Christine T Fu; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-01-05       Impact factor: 4.799

3.  Back to basics - ephrins, axonal guidance, neuroprotection and glaucoma.

Authors:  M Francesca Cordeiro; Lynda Erskine
Journal:  Br J Ophthalmol       Date:  2007-09       Impact factor: 4.638

4.  Inducible nitric oxide synthase-mediated alteration of mitochondrial OPA1 expression in ocular hypertensive rats.

Authors:  Yi Dai; Robert N Weinreb; Keun-Young Kim; Duy Nguyen; Sangwoo Park; Xinghuai Sun; James D Lindsey; Mark H Ellisman; Won-Kyu Ju
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-04-16       Impact factor: 4.799

5.  Age-dependent differences in recovered visual responses in Royal College of Surgeons rats transduced with the Channelrhodopsin-2 gene.

Authors:  Hitomi Isago; Eriko Sugano; Zhuo Wang; Namie Murayama; Eri Koyanagi; Makoto Tamai; Hiroshi Tomita
Journal:  J Mol Neurosci       Date:  2011-07-27       Impact factor: 3.444

Review 6.  High-resolution ocular imaging: combining advanced optics and microtechnology.

Authors:  M Francesca Cordeiro; Robert Nickells; Wolfgang Drexler; Terete Borrás; Robert Ritch
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2009 Sep-Oct

7.  Network analysis of human glaucomatous optic nerve head astrocytes.

Authors:  Tatiana Nikolskaya; Yuri Nikolsky; Tatiana Serebryiskaya; Svetlana Zvereva; Eugene Sviridov; Zoltan Dezso; Eugene Rahkmatulin; Richard J Brennan; Nick Yankovsky; Sanjoy K Bhattacharya; Olga Agapova; M Rosario Hernandez; Valery I Shestopalov
Journal:  BMC Med Genomics       Date:  2009-05-09       Impact factor: 3.063

8.  Immunoproteomic analysis of potential serum biomarker candidates in human glaucoma.

Authors:  Gülgün Tezel; Ivey L Thornton; Melissa G Tong; Cheng Luo; Xiangjun Yang; Jian Cai; David W Powell; Joern B Soltau; Jeffrey M Liebmann; Robert Ritch
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-13       Impact factor: 4.799

9.  Axonal/glial upregulation of EphB/ephrin-B signaling in mouse experimental ocular hypertension.

Authors:  Christine T Fu; Tony Tran; David Sretavan
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-10-08       Impact factor: 4.799

10.  Proteomics Analysis of Molecular Risk Factors in the Ocular Hypertensive Human Retina.

Authors:  Xiangjun Yang; Gözde Hondur; Ming Li; Jian Cai; Jon B Klein; Markus H Kuehn; Gülgün Tezel
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-09       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.